JLMED
Turnover is estimated at about €240,000, probably between €150,000 and €410,000. The micro format does not state turnover.
Balance sheet
balance sheet total €174,350 on 31-12-2025in euro
in euro
Key figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| 79,264 | 78,585 | 75,775 | ||
| 57,474 | 57,952 | 56,430 | ||
| 1,979 | 0 | 1,631 | ||
| 69,199 | 33,178 | - | ||
| 171,246 | 115,750 | 57,799 | ||
| 99.4% | 99.1% | 99.8% | ||
| 0.01 | 0.01 | 0.00 | ||
| 32.8% | 49.2% | 94.9% | ||
| 32.6% | 48.7% | 94.8% | ||
| 33.19 | 69.36 | over 100 |
A ratio outside any meaningful range has been withheld (balance sheet total €174,350, equity €173,245).
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Balance sheet: assets | ||||
20/58 |
174,350 | 117,545 | 59,301 | |
21/28 |
1,999 | 698 | 1,408 | |
22/27 |
1,999 | 698 | 1,408 | |
23 |
210 | 316 | 421 | |
24 |
1,789 | 383 | 987 | |
29/58 |
172,351 | 116,847 | 57,893 | |
40/41 |
2,463 | 1,284 | 5,579 | |
41 |
2,463 | 1,284 | 5,579 | |
54/58 |
138,391 | 69,192 | 36,014 | |
490/1 |
31,497 | 46,371 | 16,300 | |
| Balance sheet: equity and liabilities | ||||
10/49 |
174,350 | 117,545 | 59,301 | |
10/15 |
173,245 | 116,448 | 59,207 | |
10/11 |
3,000 | 3,000 | 3,000 | |
14 |
170,245 | 113,448 | 56,207 | |
17/49 |
1,105 | 1,097 | 94 | |
42/48 |
1,105 | 1,097 | 94 | |
44 |
1,105 | 1,097 | 94 | |
440/4 |
1,105 | 1,097 | 94 | |
| Income statement | ||||
9900 |
79,264 | 78,638 | 75,775 | |
630 |
678 | 710 | 223 | |
640/8 |
- | 53 | - | |
9901 |
78,586 | 77,875 | 75,552 | |
75/76B |
151 | 49 | 21 | |
75 |
151 | 49 | 21 | |
65/66B |
2,389 | 1,133 | 162 | |
65 |
2,389 | 1,133 | 162 | |
9903 |
76,348 | 76,791 | 75,410 | |
67/77 |
19,552 | 19,550 | 19,204 | |
9904 |
56,797 | 57,241 | 56,207 | |
9905 |
56,797 | 57,241 | 56,207 | |
| Appropriation of the result | ||||
9906 |
170,245 | 113,448 | 56,207 | |
14P |
113,448 | 56,207 | - | |
| Document | ||||
The full notes are in the accounts filed with the NBB.
Source: Annual accounts 2025 at the NBB, filed on 27-08-2026.
Filings
each dot is a set of accounts, on the day it reached the National BankThe accounts were filed on 27-08-2026. The deadline was 31-07-2026, 7 months after the close on 31-12-2025 (article 3:10 of the Companies and Associations Code). Source: NBB, 2026-00433260.
Investments
fixed assets acquired| Item | 2025 | 2024 | 2023 |
|---|---|---|---|
| Tangible fixed assets | €1,979 | - | €1,631 |
| €678 | €710 | €223 |
Source: notes to the 2023 to 2025 annual accounts (statement of fixed assets)
Insights on JLMED
The operating result for 2025 is 1% higher than in 2024 and the highest since 2023. It is the second rise in a row.
Debt's share of the balance-sheet total falls from 0.9% to 0.6%. Equity and debt are higher.